Global Retirement Partners’s Co-Diagnostics CODX Stock Holding History

Global Retirement Partners’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$310	Buy	+100	New	+$308	﹤0.01%	4339
2025 Q4	$506	Hold	100	–	–	﹤0.01%	3996
2025 Q3	$1.03K	Hold	100	–	–	﹤0.01%	3519
2025 Q2	$841	Buy	+100	New	+$935	﹤0.01%	3482
2024 Q4	$2.25K	Hold	100	–	–	﹤0.01%	3035
2024 Q3	$3.75K	Hold	100	–	–	﹤0.01%	2692
2024 Q2	$3.75K	Hold	100	–	–	﹤0.01%	2734
2024 Q1	$3.36K	Hold	100	–	–	﹤0.01%	2554
2023 Q4	$3.93K	Hold	100	–	–	﹤0.01%	2423
2023 Q3	$3.09K	Hold	100	–	–	﹤0.01%	2361
2023 Q2	$3.33K	Hold	100	–	–	﹤0.01%	2354
2023 Q1	$4.2K	Buy	+100	New	+$8.02K	﹤0.01%	2227
2020 Q2	–	Sell	-9	Closed	-$2K	–	1623
2020 Q1	$2K	Hold	9	–	–	﹤0.01%	1393
2019 Q4	$0	Buy	9 +3	+50%	+$88	﹤0.01%	1628
2019 Q3	$0	Buy	+6	New	+$199	﹤0.01%	1609

Other funds holding CODX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PAG

Private Advisory Group Redmond, Washington $1.85B AUM 50.66% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Global Retirement Partners's CODX Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Co-Diagnostics (CODX) in Q2 2026: 100 shares worth $310. The stake represents ﹤0.01% of the portfolio and ranks #4339 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in CODX as recently as Q4 2025.

Global Retirement Partners first reported a position in CODX in Q3 2019 and has held it in 15 quarters since. The position peaked at $4.2K in Q1 2023. 24 funds tracked by Wall St. Rank hold CODX as of Q2 2026.

Global Retirement Partners held 100 shares of Co-Diagnostics worth $310 as of Q2 2026.
Co-Diagnostics was a new Global Retirement Partners position in Q2 2026.
Co-Diagnostics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #4339 holding.
Global Retirement Partners first reported a position in Co-Diagnostics in Q3 2019 and has held it in 15 quarters since.
Global Retirement Partners's Co-Diagnostics position peaked at $4.2K in Q1 2023.
24 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.